Explore a comprehensive series of lectures focusing on tumor and host biology in Lynch Syndrome through three expert presentations and a panel discussion. Learn about the role of microbiome in Lynch Syndrome from Dr. Andrew Chan of Massachusetts General Hospital, discover insights into molecular profiling of Lynch Syndrome cancers with Dr. Kevin Haigis from Dana-Farber Cancer Institute, and understand how to harness the immune system for cancer risk stratification and prevention through Dr. Aysel Ahadova's research from Heidelberg University Hospital and German Cancer Research Center. Gain valuable knowledge through the concluding Q&A session where experts address audience questions about these cutting-edge topics in cancer research and treatment.
Understanding Tumor and Host Biology in Lynch Syndrome - Session 2
Dana-Farber Cancer Institute via YouTube
Overview
Syllabus
Session 2: Understanding Tumor and Host Biology
Taught by
Dana-Farber Cancer Institute
Related Courses
-
Immunotherapy to Treat Lynch Syndrome Cancers
-
Immunotherapy and Immune Prevention in Lynch Syndrome - Session 3
-
Screening and Early Detection in Lynch Syndrome: Non-Invasive Methods and Deep Learning Approaches - Session 5
-
Exercise as a Cancer Prevention Agent - Implications for Lynch Syndrome
-
Lynch Syndrome - Gene-Specific Risks and Associated Cancer Types
-
Screening and Early Detection in Lynch Syndrome - Part 1
